A two-pronged approach against glioblastoma: drug repurposing and nanoformulation design for in situ-controlled release

Glioblastoma (GB) is one of the most lethal types of neoplasms. Its biologically aggressive nature and the presence of the blood–brain barrier (BBB) limit the efficacy of standard therapies. Several strategies are currently being developed to both overcome the BBB and deliver drugs site specifically...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Maria, Branco, Francisco, Vitorino, Rui, Sousa, João, Pais, Alberto, Vitorino, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624718/
https://www.ncbi.nlm.nih.gov/pubmed/37574500
http://dx.doi.org/10.1007/s13346-023-01379-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624718/
https://www.ncbi.nlm.nih.gov/pubmed/37574500
http://dx.doi.org/10.1007/s13346-023-01379-8

Ejemplares similares